![](/img/cover-not-exists.png)
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreatedBRAF-mutated metastatic melanoma
Amin, Asim, Lawson, David H., Salama, April K.S., Koon, Henry B., Guthrie, Troy, Thomas, Sajeve S., O’Day, Steven J., Shaheen, Montaser F., Zhang, Bin, Francis, Stephen, Hodi, F. StephenVolume:
4
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-016-0148-7
Date:
December, 2016
File:
PDF, 562 KB
english, 2016